pneumonia

Pfizer’s Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the US FDA’s Approval for the Prevention of Invasive Disease and Pneumonia

Shots: The approval is based in the clinical program including P-I & II trials, and three P-III trials evaluating the safety & immunogenicity of Prevnar 20 in adults aged ≥18yrs. with invasive disease and pneumonia caused by the 20 S. pneumoniae serotypes This is the first approval of a vaccine that protects against 20 serotypes …

Pfizer’s Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the US FDA’s Approval for the Prevention of Invasive Disease and Pneumonia Read More »

Sobi and Hellenic Institute Report Results of Anakinra in P-III SAVE-MORE Study for Hospitalized Patients with COVID-19 Pneumonia

Shots: The P-III SAVE-MORE study involves assessing the efficacy and safety of anakinra (100mg/day, SC for up to 10 days) + SoC guided by suPAR vs PB0 + SOC in 600 hospitalized patients in mod. to sev. COVID-19 pneumonia over 28days across 40 sites in Greece and Italy The study demonstrated improvement in the overall …

Sobi and Hellenic Institute Report Results of Anakinra in P-III SAVE-MORE Study for Hospitalized Patients with COVID-19 Pneumonia Read More »

Roche’s Actemra/RoActemra (tocilizumab) + Veklury Fail to Meet its Primary Endpoints in P-III REMDACTA Study for Patients with Severe COVID-19 Pneumonia

Shots: The P-III REMDACTA study involves assessing Actemra/RoActemra (tocilizumab) + Veklury (remdesivir) vs PBO + Veklury in hospitalized patients with severe COVID-19 pneumonia receiving SOC The study did not meet its 1EPs i.e. improvement in time to hospital discharge up to day28 and failed to meet its 2EPs compared to Veklury alone. The findings will …

Roche’s Actemra/RoActemra (tocilizumab) + Veklury Fail to Meet its Primary Endpoints in P-III REMDACTA Study for Patients with Severe COVID-19 Pneumonia Read More »

Don’t Let the Pandemic Stop Your Shots

Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.

Don’t Let the Pandemic Stop Your Shots

Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.

Gates Foundation Awards Caption Health $4.95M Grant to Develop AI-Guided Lung Ultrasound System

What You Should Know: – Bill & Melinda Gates Foundation awards Caption Health a $4.5M grant to support the development of an AI-guided lung ultrasound system. – The grant from the Bill & Melinda Gates Foundation will be leveraged to create new AI technology that allows medical professionals without prior ultrasound experience to perform lung …

Gates Foundation Awards Caption Health $4.95M Grant to Develop AI-Guided Lung Ultrasound System Read More »

Mobile Point-of-Care Ultrasound Is Now A Frontline Warrior in Pandemic

Diku Mandavia, M.D., SVP, Chief Medical Officer at FUJIFILM Sonosite Health authorities need to prioritize delivery and the repurposing of mobile point-of-care ultrasound machines which have proven to be reliable, affordable, and effective in saving the lives of coronavirus patients.   Most Americans are familiar with ultrasound technology from the scans done to check on the …

Mobile Point-of-Care Ultrasound Is Now A Frontline Warrior in Pandemic Read More »

Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap

Oliver Schacht, PhD, CEO of OpGen Secondary bacterial or fungal co-infections in COVID-19 patients have received inadequate attention from the public. For most, co-infections pose little to no risk according to reports that an estimated 8% of patients are found to experience this during hospital admission – a relatively low number compared to the global impact of the …

Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap Read More »